世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

PEG化タンパク質市場：製品（消耗品、サービス）、タンパク質タイプ（コロニー刺激因子、インターフェロン、エリスロポエチン、mAbs、組み換え第VII因子、その他）、用途（がん治療、肝炎、慢性腎臓病、血友病、多発性硬化症、消化器疾患、その他）、エンドユーザー（製薬・バイオ企業、受託研究機関、学術・研究機関）、地域別 2023-2028


PEGylated Proteins Market by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2023-2028

市場の概要 世界のPEG化タンパク質の市場規模は、2022年に11億6000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に10.16%の成長率（CAGR）を示し、2028年までに21億3000万米ドルに達する... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
IMARC Services Private Limited.
アイマークサービス 		2023年3月18日 US$2,499
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		145 英語

　

サマリー

市場の概要

世界のPEG化タンパク質の市場規模は、2022年に11億6000万米ドルに達しました。今後、IMARC Groupは、2023年から2028年の間に10.16%の成長率（CAGR）を示し、2028年までに21億3000万米ドルに達すると予測しています。慢性疾患の増加、がん治療における製品の利用拡大、PEG化タンパク質の製品承認数の増加が、市場を牽引する重要な要因の一部となっています。

PEG化タンパク質は、ポリエチレングリコール（PEG）との共有結合によって修飾された生体分子である。PEG化技術により、生体分子の立体構造、静電結合、疎水性などの物理的・化学的特性を変化させ、医薬品の薬物動態を改善するものです。PEG化タンパク質は、ワクチン、ホルモン補充療法、遺伝子疾患、貧血、血液凝固障害などの治療用途に広く使用されています。また、腎臓病、多発性硬化症、血友病、癌などの疾患に対する様々な薬剤に使用されています。PEG化タンパク質は、半減期の延長、安定性、溶解性、タンパク質分解保護の向上、腎排泄、免疫原性、毒性の低減、ドラッグデリバリーの有効性の向上に役立っています。さらに、PEG化タンパク質は、毒性がなく、水溶性で、親水性、非抗原性、非免疫原性です。

PEG化プロテインの市場動向：

腎臓病、自己免疫疾患、遺伝性疾患、肝炎、関節リウマチなどの慢性疾患の世界的な流行が、市場成長を促進する重要な要因の一つとなっています。PEG化タンパク質は、炎症の治療、細胞への修正遺伝子の導入、血栓の予防、成長ホルモンの導入、慢性腎臓病の進行防止などに広く使用されています。これに伴い、化学療法薬をがん細胞に直接投与し、健康な細胞への副作用を軽減するために、がん治療で広く製品が利用されていることが、市場の成長に好影響を与えています。これとは別に、より小さく、より複雑な分子を生成できる新しいPEG化法の開発など、PEG化技術におけるさまざまな改良が、市場成長の原動力となっています。さらに、コロニー刺激因子（CSF）の安定性と半減期を改善し、治療薬としてより効果的にするためにPEG化技術が広く採用されていることも、成長を促進する要因となっています。さらに、PEG化によってタンパク質の循環と半減期が向上し、効率が改善する非タンパク質ベースの薬剤よりも、タンパク質ベースの薬剤の採用が増加していることも、市場の成長を後押ししています。その他、PEG化タンパク質の製品承認数の増加、バイオテクノロジーと分子生物学工学分野の発展、バイオ医薬品におけるPEG分子の統合と関連する利点、老人人口の増加、医薬品業界の規制基準を高めるためのさまざまな政府の取り組みの実施などが、市場をさらに成長へと導くと予想されています。

主要な市場セグメント：

IMARC Groupは、世界のPEG化タンパク質市場の各セグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を提供します。当レポートでは、製品、タンパク質の種類、用途、エンドユーザーに基づいて市場を分類しています。

製品のインサイトです：

消耗品

PEG化試薬
PEG化キット


サービス内容


また、本レポートでは、製品に基づくPEG化タンパク質市場の詳細な内訳と分析も提供しています。これには、消耗品（PEgylation試薬、PEgylationキット）、サービスが含まれます。それによると、消耗品が最大の市場シェアを占めています。

プロテインタイプのインサイト

コロニー形成促進因子（Colony Stimulating Factors
インターフェロン
エリスロポイエチン
mAbs
リコンビナントファクターVII
その他


本レポートでは、PEG化タンパク質市場について、タンパク質の種類に基づく詳細な分解と分析を行っています。これには、コロニー刺激因子、インターフェロン、エリスロポエチン、mAbs、遺伝子組換え第VII因子、その他が含まれます。それによると、コロニー刺激因子が最も大きなセグメントを占めています。

アプリケーションインサイト

がん治療
肝炎
慢性腎臓病
血友病
多発性硬化症（Multiple Sclerosis
消化器系疾患
その他


また、PEG化タンパク質市場の用途に基づく詳細な分解と分析も本レポートで提供されています。これには、がん治療、肝炎、慢性腎臓病、血友病、多発性硬化症、胃腸障害、その他が含まれます。報告書によると、がん治療が最大のセグメントを占めています。

エンドユーザーのインサイト：

製薬会社・バイオテクノロジー企業
受託研究機関
学術・研究機関


本レポートでは、PEG化タンパク質市場をエンドユーザーに基づき詳細に分解・分析しています。これには、製薬・バイオテクノロジー企業、受託研究機関、学術・研究機関などが含まれます。それによると、製薬会社およびバイオテクノロジー会社が最大のセグメントを占めています。

地域別インサイト

北アメリカ

ユーエスエー
カナダ


ヨーロッパ

ドイツ
フランス
イギリス
イタリア
スペイン
ロシア
その他


アジア太平洋

中国
日本
インド
南朝鮮
オーストラリア
インドネシア
その他


ラテンアメリカ

ブラジル
メキシコ
その他


中近東・アフリカ


また、北米（米国、カナダ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、中南米（ブラジル、メキシコ、その他）、中東・アフリカを含むすべての主要地域市場について包括的に分析を行っています。それによると、PEG化タンパク質の最大市場は北米であった。北米のPEG化タンパク質市場を牽引する要因として、老人人口の増加、慢性疾患の有病率の増加、大規模な研究開発（R&D）などが挙げられます。

競合の状況：

また、世界のPEG化タンパク質市場における競争環境についても包括的な分析がなされています。市場構造、主要プレイヤーによる市場シェア、プレイヤーのポジショニング、トップの勝利戦略、競合ダッシュボード、企業評価象限などの競争分析がレポート内で取り上げられています。また、すべての主要企業の詳細なプロフィールが提供されています。対象となる企業には、Abcam plc、Biomatrik Inc.、Creative PEGWorks、Iris Biotech GmbH、JenKem Technology USA Inc.、Laysan Bio Inc.、NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc.など。なお、これは企業の一部のリストであり、完全なリストは報告書に記載されています。

本レポートで回答した主な質問
PEG化タンパク質の世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
世界のPEG化タンパク質市場における推進要因、阻害要因、機会は何か？
各ドライバー、阻害要因、機会が世界のPEG化タンパク質市場に与える影響は？
主要な地域市場とは？
最も魅力的なPEG化タンパク質市場はどの国か？
製品に基づく市場の内訳は？
PEG化タンパク質市場で最も魅力的な製品は何か？
タンパク質の種類に基づく市場の内訳は？
PEG化タンパク質市場で最も魅力的なタンパク質タイプはどれか？
アプリケーションに基づく市場の内訳は？
PEG化タンパク質市場で最も魅力的なアプリケーションはどれか？
エンドユーザーに基づく市場の内訳は？
PEG化タンパク質市場で最も魅力的なエンドユーザーはどこか？
PEG化タンパク質の世界市場の競争構造は？
PEG化タンパク質の世界市場における主要プレイヤー/企業は？

ページTOPに戻る


目次

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global PEGylated Proteins Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 PEGylation Reagents    
           6.1.2.2 PEGylation Kits    
        6.1.3 Market Forecast
    6.2    Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Protein Type
    7.1    Colony Stimulating Factors
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Interferons
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Erythropoietin
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    mAbs
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Recombinant Factor VII
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Application
    8.1    Cancer Treatment
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hepatitis
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Chronic Kidney Diseases
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Hemophilia
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Multiple Sclerosis
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Gastrointestinal Disorders
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9    Market Breakup by End User
    9.1    Pharmaceutical and Biotechnology Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Contract Research Organizations
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Academic and Research Institutes
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    Drivers, Restraints, and Opportunities
    11.1    Overview
    11.2    Drivers
    11.3    Restraints
    11.4    Opportunities
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abcam plc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Biomatrik Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Creative PEGWorks
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Iris Biotech GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    JenKem Technology USA Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Laysan Bio Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    NOF America Corporation (NOF Corporation)
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Profacgen
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Thermo Fisher Scientific Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2022
Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2022
Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2022
Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2022
Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2022
Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: China: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: India: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: France: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2022
Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million US$), 2023-2028
Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: PEGylated Proteins Market: Competitive Structure
Table 8: Global: PEGylated Proteins Market: Key Players

　

ページTOPに戻る


　

Summary

Market Overview:

The global PEGylated proteins market size reached US$ 1.16 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.13 Billion by 2028, exhibiting a growth rate (CAGR) of 10.16% during 2023-2028. The increasing prevalence of chronic diseases, the widespread product utilization in cancer treatment, and the escalating number of product approvals for PEGylated proteins represent some of the key factors driving the market.

PEGylated proteins are biomolecules that have been modified by covalent conjugation with polyethylene glycol (PEG). It involves the PEGylation technique that improves the pharmacokinetic behavior of the medicine by altering the biological molecule's physical and chemical characteristics, such as its conformation, electrostatic binding, and hydrophobicity. PEGylated proteins are widely used in therapeutic applications, such as vaccines, hormone replacement therapy, genetic disorders, anemia, and blood clotting disorder. It is also used in various drugs for diseases, including kidney disease, multiple sclerosis, hemophilia, and cancers. PEGylated proteins help in the extension of half-life, increasing stability, solubility, and proteolytic protection, reducing renal excretion, immunogenicity, and toxicity, and enhancing the efficacy of drug delivery. Besides this, PEGylated proteins are non-toxic, water-soluble, hydrophilic, non-antigenic, and non-immunogenic.

PEGylated Proteins Market Trends:

The rising prevalence of chronic diseases, such as kidney ailments, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis across the globe is one of the key factors driving the market growth. PEGylated proteins are widely used to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and prevent the progression of chronic kidney disease. In line with this, the widespread product utilization in cancer treatment to deliver chemotherapy drugs directly to cancer cells and reduce the side effects on healthy cells is favoring the market growth. Apart from this, various improvements in the PEGylation technology, such as the development of new PEGylation methods that can produce smaller and more complex molecules, are providing an impetus to the market growth. Additionally, the widespread adoption of PEGylation to improve the stability and half-life of colony-stimulating factors (CSFs), making them more effective as therapeutic agents, is acting as another growth-inducing factor. Furthermore, the rising adoption of protein-based drugs over non-protein-based drugs wherein PEGylation increases the circulation and half-life of the proteins, improving its efficiency, is propelling the market growth. Other factors, including the increasing number of product approvals for PEGylated proteins, development in the field of biotechnology and molecular biology engineering, the integration of PEG molecules in biopharmaceuticals and the associated advantages, rising geriatric population, and the implementation of various government initiatives to increase regulatory standards in the pharmaceutical industry, are anticipated drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global PEGylated proteins market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on product, protein type, application, and end user.

Product Insights:

Consumables

PEGylation Reagents
PEGylation Kits


Services


A detailed breakup and analysis of the PEGylated proteins market based on the product has also been provided in the report. This includes consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.

Protein Type Insights:

Colony Stimulating Factors
Interferons
Erythropoietin
mAbs
Recombinant Factor VII
Others


The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the protein type. This includes colony stimulating factors, interferons, erythropoietin, mAbs, recombinant factor VII and others. According to the report, colony stimulating factors represented the largest segment.

Application Insights:

Cancer Treatment
Hepatitis
Chronic Kidney Diseases
Hemophilia
Multiple Sclerosis
Gastrointestinal Disorders
Others


A detailed breakup and analysis of the PEGylated proteins market based on the application has also been provided in the report. This includes cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and others. According to the report, cancer treatment represented the largest segment.

End User Insights:

Pharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic and Research Institutes


The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the end user. This includes pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Regional Insights:

North America

United States
Canada


Europe

Germany
France
United Kingdom
Italy
Spain
Russia
Others


Asia Pacific

China
Japan
India
South Korea
Australia
Indonesia
Others


Latin America

Brazil
Mexico
Others


Middle East and Africa


The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins. Some of the factors driving the North America PEGylated proteins market included the rising geriatric population, increasing prevalence of chronic diseases, and extensive research and development (R&D).

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global PEGylated proteins market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:
How has the global PEGylated proteins market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global PEGylated proteins market?
What is the impact of each driver, restraint, and opportunity on the global PEGylated proteins market?
What are the key regional markets?
Which countries represent the most attractive PEGylated proteins markets?
What is the breakup of the market based on the product?
Which is the most attractive product in the PEGylated proteins market?
What is the breakup of the market based on the protein type?
Which is the most attractive protein type in the PEGylated proteins market?
What is the breakup of the market based on the application?
Which is the most attractive application in the PEGylated proteins market?
What is the breakup of the market based on the end user?
Which is the most attractive end user in the PEGylated proteins market?
What is the competitive structure of the global PEGylated proteins market?
Who are the key players/companies in the global PEGylated proteins market?



ページTOPに戻る


Table of Contents

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction
    4.1    Overview
    4.2    Key Industry Trends
5    Global PEGylated Proteins Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Consumables
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 PEGylation Reagents    
           6.1.2.2 PEGylation Kits    
        6.1.3 Market Forecast
    6.2    Services
        6.2.1 Market Trends
        6.2.2 Market Forecast
7    Market Breakup by Protein Type
    7.1    Colony Stimulating Factors
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Interferons
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Erythropoietin
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    mAbs
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Recombinant Factor VII
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by Application
    8.1    Cancer Treatment
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Hepatitis
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Chronic Kidney Diseases
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Hemophilia
        8.4.1 Market Trends
        8.4.2 Market Forecast
    8.5    Multiple Sclerosis
        8.5.1 Market Trends
        8.5.2 Market Forecast
    8.6    Gastrointestinal Disorders
        8.6.1 Market Trends
        8.6.2 Market Forecast
    8.7    Others
        8.7.1 Market Trends
        8.7.2 Market Forecast
9    Market Breakup by End User
    9.1    Pharmaceutical and Biotechnology Companies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Contract Research Organizations
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Academic and Research Institutes
        9.3.1 Market Trends
        9.3.2 Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia-Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11    Drivers, Restraints, and Opportunities
    11.1    Overview
    11.2    Drivers
    11.3    Restraints
    11.4    Opportunities
12    Value Chain Analysis
13    Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Abcam plc
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio
           15.3.1.3 Financials
           15.3.1.4 SWOT Analysis
        15.3.2    Biomatrik Inc.
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
        15.3.3    Creative PEGWorks
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio
        15.3.4    Iris Biotech GmbH
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio
        15.3.5    JenKem Technology USA Inc.
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio
        15.3.6    Laysan Bio Inc.
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio
        15.3.7    NOF America Corporation (NOF Corporation)
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
        15.3.8    Profacgen
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio
        15.3.9    Thermo Fisher Scientific Inc.
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials
           15.3.9.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report

List of Figures

Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2022
Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2022
Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2022
Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2022
Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2022
Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million US$), 2017 & 2022
Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million US$), 2017 & 2022
Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million US$), 2017 & 2022
Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million US$), 2017 & 2022
Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million US$), 2017 & 2022
Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million US$), 2017 & 2022
Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million US$), 2017 & 2022
Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million US$), 2017 & 2022
Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 53: China: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 57: India: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 71: France: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million US$), 2017 & 2022
Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2022
Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2022 & 2028
Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million US$), 2023-2028
Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million US$), 2023-2028
Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million US$), 2023-2028
Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million US$), 2023-2028
Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 7: Global: PEGylated Proteins Market: Competitive Structure
Table 8: Global: PEGylated Proteins Market: Key Players

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

IMARC Services Private Limited.社の医療分野での最新刊レポート

本レポートと同じKEY WORD（contract）の最新刊レポート


よくあるご質問


IMARC Services Private Limited.社はどのような調査会社ですか?


インドに調査拠点を持つ調査会社。幅広い分野をカバーしていますがケミカルに特に焦点を当てています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.